Scott D. Solomon, MD is the Edward D. Frohlich Distinguished Chair, Professor of Medicine at Harvard Medical School and Brigham and Women’s Hospital. He directs the Clinical Trials Outcomes Center and the Cardiac Imaging Core Laboratory and directed Noninvasive Cardiology from 2000-2020. His research interests have focused on understanding the effects of heart failure on cardiac structure and function, modifiers of risk and outcomes in heart failure, and therapeutics for heart failure. He is a world-renowned clinical trialist, having led numerous phase 2 and phase 3 clinical trials in heart failure, including in patients heart failure with reduced ejection fraction, mildly reduced and preserved ejection fraction, amyloidosis and hypertrophic cardiomyopathy. His work has led to the introduction of several key therapeutics in heart failure, including sacubitril/valsartan, and SGLT2 inhibitors for heart failure. He has published more than 1000 peer-reviewed articles, three textbooks of echocardiography, and he serves as Editor for Braunwald’s Heart Disease.